Sharps Technology

Melville, United States

Sharps Technology makes single-use syringes that help prevent accidental needle sticks and make injections safer

$400.0M raised

Aug 2025

Post-IPO Equity

Biotechnology Decentralized Finance (DeFi)Health Care Medical Device Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sharps Technology

How much funding has Sharps Technology raised?

Sharps Technology has raised $400.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in August 2025.

Where is Sharps Technology headquartered?

Sharps Technology is headquartered in Melville, United States.

What does Sharps Technology do?

Sharps Technology makes single-use syringes that help prevent accidental needle sticks and make injections safer

What stage is Sharps Technology at?

Sharps Technology is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 25, 2025.

MLA

"Sharps Technology — Funding & Investors." VCBacked, August 25, 2025, https://www.vcbacked.co/company/sharps-technology. Accessed July 3, 2026.

APA

VCBacked. (2025). Sharps Technology — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/sharps-technology

Wikipedia (cite web)

{{cite web |title=Sharps Technology — Funding & Investors |url=https://www.vcbacked.co/company/sharps-technology |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 25, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K